Introduction and Objective: This study examines the impact of online, virtual patient simulation (VPS)-based continuing medical education (CME) on performance related to diagnosis and management of T2D by diabetologists/endocrinologists (D/Es) and primary care physicians (PCPs).Methods: Intervention was 2 patient scenarios presenting in a VPS. Clinical guidance (CG) based on evidence was provided following each decision, followed by the opportunity to modify the decision. Decisions were collected post-CG and compared with each user’s baseline (pre-CG) using a McNemar’s test to determine P values. Data collected January-April 2024.Results: 37 D/Es and 303 PCPs were included. Case 1: 45 YO male with T2D with fatigue, shaking, sweating, and weight gain. D/Es: Diagnose uncontrolled T2D: 27% absolute improvement (P<.01; baseline 38%), Guideline-based treatment: 27% absolute improvement (P<.01; baseline 46%), PCPs: Diagnose uncontrolled T2D: 27% absolute improvement (P<.001; baseline 32%), Guideline-based treatment: 30% absolute improvement (P<.001; baseline 21%). Case 2: 50 YO woman with mild fatigue D/Es: Diagnose T2D: 45% absolute improvement (P<.001; baseline 17%) Guideline-based treatment: 38% absolute improvement (P<.001; baseline 33%). PCPs: Diagnose T2D: 44% absolute improvement (P<.001; baseline 18%) Guideline-based treatment: 25% absolute improvement (P<.001; baseline 22%). Top Rationales for Prescribing GLP-1 RAs were guidelines: (40%) and efficacy (37%). Top Rationales for NOT Prescribing GLP-1 RAs were Cost (14%) and Unfamiliar with use (11%). Continued Gaps: 50% of PCPs and 30% D/Es failed to select guideline-recommended treatment, with biggest gaps in case 2 (patient with newly diagnosed T2D), demonstrating a need for additional education on first-line treatment.Conclusion: VPS can improve evidence-based clinical decisions by D/Es and PCPs related to diagnosis and management of T2D. Continued gaps were identified for future educational initiatives.
A. Larkin: None. M. LaCouture: None. A. Le: None.
Independent educational grant from Novo Nordisk.
Source link
Leave a Reply